163 related articles for article (PubMed ID: 20153003)
1. Changes in α-glucosidase activities along the jejunal-ileal axis of normal rats by the α-glucosidase inhibitor miglitol.
Mochizuki K; Hanai E; Suruga K; Kuranuki S; Goda T
Metabolism; 2010 Oct; 59(10):1442-7. PubMed ID: 20153003
[TBL] [Abstract][Full Text] [Related]
2. Changes in mucosal alpha-glucosidase activities along the jejunal-ileal axis by an Hm-HACS diet intake are associated with decreased lipogenic enzyme activity in epididymal adipose tissue.
Mochizuki K; Sato Y; Takase S; Goda T
J Agric Food Chem; 2010 Jun; 58(11):6923-7. PubMed ID: 20481469
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
Deshpande MC; Venkateswarlu V; Babu RK; Trivedi RK
Int J Pharm; 2009 Oct; 380(1-2):16-24. PubMed ID: 19563873
[TBL] [Abstract][Full Text] [Related]
4. Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes.
Mochizuki K; Fukaya N; Tanaka Y; Fuchigami M; Goda T
Metabolism; 2011 Nov; 60(11):1560-5. PubMed ID: 21550076
[TBL] [Abstract][Full Text] [Related]
5. The alpha-glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin-1beta and tumour necrosis factor-alpha gene expression in rat peripheral leucocytes induced by intermittent sucrose loading.
Tanaka Y; Mochizuki K; Fukaya N; Shimada M; Goda T
Br J Nutr; 2009 Jul; 102(2):221-5. PubMed ID: 19138443
[TBL] [Abstract][Full Text] [Related]
6. The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes.
Fukaya N; Mochizuki K; Shimada M; Goda T
Nutrition; 2009 Jun; 25(6):657-67. PubMed ID: 19216056
[TBL] [Abstract][Full Text] [Related]
7. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.
Osonoi T; Saito M; Mochizuki K; Fukaya N; Muramatsu T; Inoue S; Fuchigami M; Goda T
Metabolism; 2010 Dec; 59(12):1816-22. PubMed ID: 20667563
[TBL] [Abstract][Full Text] [Related]
8. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice.
Hamada Y; Nagasaki H; Fuchigami M; Furuta S; Seino Y; Nakamura J; Oiso Y
Metabolism; 2013 May; 62(5):734-42. PubMed ID: 23194643
[TBL] [Abstract][Full Text] [Related]
9. Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats.
Goda T; Suruga K; Komori A; Kuranuki S; Mochizuki K; Makita Y; Kumazawa T
Br J Nutr; 2007 Oct; 98(4):702-10. PubMed ID: 17537288
[TBL] [Abstract][Full Text] [Related]
10. Effect of miglitol, an alpha-glucosidase inhibitor, on atherogenic outcomes in balloon-injured diabetic rats.
Hirata A; Igarashi M; Iwai H; Tominaga M
Horm Metab Res; 2009 Mar; 41(3):213-20. PubMed ID: 19085811
[TBL] [Abstract][Full Text] [Related]
11. Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus.
Yokoyama H; Kannno S; Ishimura I; Node K
Metabolism; 2007 Nov; 56(11):1458-63. PubMed ID: 17950094
[TBL] [Abstract][Full Text] [Related]
12. The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats.
Fukaya N; Mochizuki K; Tanaka Y; Kumazawa T; Jiuxin Z; Fuchigami M; Goda T
Eur J Pharmacol; 2009 Dec; 624(1-3):51-7. PubMed ID: 19818342
[TBL] [Abstract][Full Text] [Related]
13. [Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol].
Fehmann HC
MMW Fortschr Med; 2000 May; 142(21):55. PubMed ID: 10872296
[No Abstract] [Full Text] [Related]
14. Amino acids in the rat intestinal lumen regulate their own absorption from a distant intestinal site.
Mourad FH; Barada KA; Khoury C; Hamdi T; Saadé NE; Nassar CF
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G292-8. PubMed ID: 19541927
[TBL] [Abstract][Full Text] [Related]
15. Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase.
Jones K; Sim L; Mohan S; Kumarasamy J; Liu H; Avery S; Naim HY; Quezada-Calvillo R; Nichols BL; Pinto BM; Rose DR
Bioorg Med Chem; 2011 Jul; 19(13):3929-34. PubMed ID: 21669536
[TBL] [Abstract][Full Text] [Related]
16. Starch digestion, large-bowel fermentation and intestinal mucosal cell proliferation in rats treated with the alpha-glucosidase inhibitor acarbose.
Dehghan-Kooshkghazi M; Mathers JC
Br J Nutr; 2004 Mar; 91(3):357-65. PubMed ID: 15005821
[TBL] [Abstract][Full Text] [Related]
17. Isocal and Portagen alter intestinal uptake of sugars but not mucosal surface area in rabbits with an intact intestinal tract and following ileal resection.
Thomson AB; Keelan M
Clin Invest Med; 1987 Nov; 10(6):520-9. PubMed ID: 3440339
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ficus racemosa stem bark on the activities of carbohydrate hydrolyzing enzymes: an in vitro study.
Ahmed F; Urooj A
Pharm Biol; 2010 May; 48(5):518-23. PubMed ID: 20645793
[TBL] [Abstract][Full Text] [Related]
19. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.
Renard E; Parer-Richard C; Richard JL; Jureidini S; Orsetti A; Mirouze J
Diabete Metab; 1991; 17(3):355-62. PubMed ID: 1884880
[TBL] [Abstract][Full Text] [Related]
20. Bilirubin impairs intestinal regrowth following massive small bowel resection in a rat model.
Sukhotnik I; Shaoul R; Lieber M; Coran AG; Abassi Z; Shiloni E; Mogilner JG
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):16-22. PubMed ID: 19465868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
